Loading market dashboard
Prime Medicine, Inc.
PRMEHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Prime Medicine, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $60.06M | $6.73M - $200.64M | $12.01M | -$0.822 | 5 |
| Dec 2029 | $18.36M | $2.06M - $61.32M | $3.67M | -$0.934 | 5 |
| Dec 2028 | $31.31M | $3.51M - $104.59M | $6.26M | -$0.815 | 10 |
| Dec 2027 | $22.52M | $3.84M - $56.18M | $4.50M | -$0.909 | 8 |
| Dec 2026 | $12.93M | $863.3K - $50.19M | $2.59M | -$0.997 | 10 |
| Dec 2025 | $4.97M | $3.50M - $6.59M | $993.5K | -$1.339 | 8 |
| Dec 2024 | $11.55M | $5.89M - $22.81M | $2.31M | -$1.60 | 8 |
| Dec 2023 | $591.0K | $175.4K - $1.34M | $118.2K | -$2.157 | 7 |
| Dec 2022 | $4.00M | $2.76M - $7.59M | $1.46M | -$4.18 | 6 |